Prostate cancer is the second most common cancer in American men, with Los Angeles County recording tens of thousands of new diagnoses annually. For patients with metastatic castration-resistant prostate cancer (mCRPC) in Los Angeles, Abiraterone Acetate — sold under the brand name Zytiga and now available as the Indian generic Abiranamo 250mg — is a life-extending treatment that significantly slows cancer progression.
Abiranamo 250mg contains Abiraterone Acetate, a potent CYP17A1 inhibitor that blocks androgen biosynthesis in the adrenal glands, testes, and within the prostate tumour itself. When combined with low-dose prednisone, it reduces testosterone to near-castrate levels even in patients who have already undergone surgical or chemical castration. Clinical trials demonstrated that Abiraterone extended median overall survival by over 4 months in post-chemotherapy mCRPC patients and significantly delayed disease progression in chemotherapy-naive patients.
Brand-name Zytiga in Los Angeles costs over $9,000 per month without insurance — well beyond the reach of many prostate cancer patients, particularly those who are uninsured, underinsured, or on fixed incomes. Generic Abiranamo from India, manufactured in WHO-GMP and USFDA-certified facilities, delivers the same clinical outcomes at up to 95% lower cost, making continued life-extending therapy financially sustainable.
Unnati Pharmax supplies Abiranamo 250mg to oncology pharmacies, prostate cancer patients, and distributors in Los Angeles and across the USA. Visit medshopy.com or WhatsApp +91 82650 41513 for pricing and availability.
Abiranamo 250mg contains Abiraterone Acetate, a potent CYP17A1 inhibitor that blocks androgen biosynthesis in the adrenal glands, testes, and within the prostate tumour itself. When combined with low-dose prednisone, it reduces testosterone to near-castrate levels even in patients who have already undergone surgical or chemical castration. Clinical trials demonstrated that Abiraterone extended median overall survival by over 4 months in post-chemotherapy mCRPC patients and significantly delayed disease progression in chemotherapy-naive patients.
Brand-name Zytiga in Los Angeles costs over $9,000 per month without insurance — well beyond the reach of many prostate cancer patients, particularly those who are uninsured, underinsured, or on fixed incomes. Generic Abiranamo from India, manufactured in WHO-GMP and USFDA-certified facilities, delivers the same clinical outcomes at up to 95% lower cost, making continued life-extending therapy financially sustainable.
Unnati Pharmax supplies Abiranamo 250mg to oncology pharmacies, prostate cancer patients, and distributors in Los Angeles and across the USA. Visit medshopy.com or WhatsApp +91 82650 41513 for pricing and availability.
